Cubase Bio raises €5.9M Seed round
17 February 2026· Stockholm, Sweden· health, life_sciences, biotech, ai, b2b, software_hardware
The funding will be used to accelerate the technology development and commercialization of the company's next-generation spatial transcriptomic technology, which enables true 3D spatial analysis for drug discovery and disease research.
Investors
LeadVoima Ventures
Also participating
Almi InvestIllumina VenturesNordic Science InvestmentsLife Science Invest
About Cubase Bio
Stage
Seed
Headquarters
Stockholm, Sweden
Founded
2024
Team Size
6–20
Sectors
healthlife_sciencesbiotechaib2bsoftware_hardware